bendroflumethiazide has been researched along with Hypophosphatemia in 1 studies
Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.
Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pope, RM | 1 |
| Belchetz, PE | 1 |
1 other study available for bendroflumethiazide and Hypophosphatemia
| Article | Year |
|---|---|
Hypophosphataemic osteomalacia due to urinary kappa light chain.
Topics: Bendroflumethiazide; Drug Therapy, Combination; Humans; Hypophosphatemia; Immunoglobulin kappa-Chain | 1993 |